标题
Toxicity profiling of several common RNAi-based nanomedicines: a comparative study
作者
关键词
RNAi, Nanomedicines, Nanotoxicity, Cationic liposomes, Polyamines
出版物
Drug Delivery and Translational Research
Volume 4, Issue 1, Pages 96-103
出版商
Springer Nature
发表日期
2013-05-29
DOI
10.1007/s13346-013-0158-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles
- (2012) Dan Peer ADVANCED DRUG DELIVERY REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma
- (2012) Shiri Weinstein et al. PLoS One
- The association of autophagy with polyethylenimine-induced cytotoxity in nephritic and hepatic cell lines
- (2011) Xiaoling Gao et al. BIOMATERIALS
- Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice
- (2011) Jianfeng Guo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Special delivery: targeted therapy with small RNAs
- (2011) D Peer et al. GENE THERAPY
- Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
- (2011) Shoshy Mizrahy et al. JOURNAL OF CONTROLLED RELEASE
- Altering the immune response with lipid-based nanoparticles
- (2011) Dalit Landesman-Milo et al. JOURNAL OF CONTROLLED RELEASE
- Grand challenges in modulating the immune response with RNAi nanomedicines
- (2011) Meir Goldsmith et al. Nanomedicine
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
- (2010) Ilia Rivkin et al. BIOMATERIALS
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
- (2010) Ranit Kedmi et al. BIOMATERIALS
- Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes
- (2010) Sabrina Höbel et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- RNAi and small interfering RNAs in human disease therapeutic applications
- (2010) Monica R. Lares et al. TRENDS IN BIOTECHNOLOGY
- Nanomedicine based approaches for the delivery of siRNA in cancer
- (2009) B. Ozpolat et al. JOURNAL OF INTERNAL MEDICINE
- The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice
- (2009) Shan Gao et al. MOLECULAR THERAPY
- RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice
- (2009) Sang-Soo Kim et al. MOLECULAR THERAPY
- Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas
- (2008) Rade Injac et al. BIOMATERIALS
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor
- (2008) Sumio Chono et al. JOURNAL OF CONTROLLED RELEASE
- Breathing Life into Polycations: Functionalization with pH-Responsive Endosomolytic Peptides and Polyethylene Glycol Enables siRNA Delivery
- (2008) Martin Meyer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
- (2008) Akin Akinc et al. NATURE BIOTECHNOLOGY
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started